-
-
-
-
-
-
-
Teva Pharma (TEVA) PT Raised to $45 at Truist Securities
-
-
-
-
-
-
-
Teva Announces Successful Upsizing and Pricing of $2,300,000,000 (Equivalent) Senior Notes; Proceeds to Repay Existing Debt
-
-
-
-
-
-
-
4 small and mid-cap biopharma stocks to own according to BofA
-
-
-
-
-
-
-
Teva (TEVA) and Alvotech (ALVO) Provide Update on Partnership
-
-
-
-
-
-
-
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
-
-
-
-
-
-
-
Teva Pharma (TEVA) Announces Nationwide Opioids Settlement
-
-
-
-
-
-
-
Teva Finalizes Nationwide Opioid Settlement Terms
-
1,177,149 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

